Overview and Scope
Whole genome sequencing (WGS) and exome sequencing (ES) are comprehensive genetic analysis techniques that involve determining the complete DNA sequence of an organism’s genome and sequencing the protein-coding regions of the genome. These analyses are used to sequence a person’s DNA for diagnosing genetic diseases and identifying cancer mutations.
Sizing and Forecast
The whole genome and exome sequencing market size has grown exponentially in recent years. It will grow from $1.61 billion in 2023 to $2.02 billion in 2024 at a compound annual growth rate (CAGR) of 25.5%. Thegrowth in the historic period can be attributed to decreasing sequencing costs, rise in genetic disorders, clinical applications, genomic data repositories, advancements in bioinformatics.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report
Segmentation & Regional Insights
The whole genome and exome sequencing market covered in this report is segmented –
1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
North America was the largest region in the whole genome and exome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp
Major Driver Impacting Market Growth
The rising demand for personalized medicine is expected to propel the growth of the whole genome and exome sequencing market in the future. Personalized medicine is an approach to medical treatment that tailors healthcare decisions and interventions to the individual characteristics of each patient, considering factors such as genetics, environment, and lifestyle. Whole genome and exome sequencing is used in personalized medicine by providing a comprehensive analysis of an individual’s genetic makeup, allowing for tailored healthcare decisions and interventions based on their unique genetic, environmental, and lifestyle factors. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes the understanding and adoption of personalized medicine, more than 75,000 genetic testing products and 300 personalized medicines are expected to be on the market in 2022. Furthermore, the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs) in 2022. Further, out of the 35 therapeutic NMEs, approximately 34%, which amounts to 12 of them, are classified as personalized. Therefore, the rising demand for personalized medicine is driving the growth of the whole genome and exome sequencing market.
Key Industry Players
Major companies operating in the whole genome and exome sequencing market report are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V, Neusoft Corporation, BGI Genomics, Mirion Technologies (Capintec) Inc., Novogene Co., Oxford Nanopore Technologies Inc., LANDAUER, Pacific Biosciences of California Inc., Digirad Corporation, Berthold Technologies GmbH & Co.KG, GENEWIZ Inc., Incom Inc., Lucerno Dynamics LLC, Absolute Imaging Inc., Mediso Ltd., Ashby Gorman Baker Ltd., DDD-Diagnostic AS, SurgicEye GmbH, CMR Naviscan
The whole genome and exome sequencing market report table of contents includes:
1. Executive Summary
.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The building-to-grid technology global market report 2024 from The Business Research Company provides comprehensive market…
The automatic bread machine global market report 2024 from The Business Research Company provides comprehensive…
The acrylic surface coating global market report 2024 from The Business Research Company provides comprehensive…
The vehicle-to-infrastructure (v2i) communication global market report 2024 from The Business Research Company provides comprehensive…
The solvent-based inks global market report 2024 from The Business Research Company provides comprehensive market…
The remote browser isolation global market report 2024 from The Business Research Company provides comprehensive…